Price T Rowe Associates Inc Avid Bioservices, Inc. Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
A detailed history of Price T Rowe Associates Inc transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 33,032 shares of CDMO stock, worth $362,691. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,032
Previous 30,299
9.02%
Holding current value
$362,691
Previous $204,000
15.69%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding CDMO
# of Institutions
177Shares Held
68.4MCall Options Held
21.3KPut Options Held
110K-
Black Rock Inc. New York, NY5.11MShares$56.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.1MShares$56 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.8MShares$41.7 Million0.0% of portfolio
-
12 West Capital Management LP New York, NY3.65MShares$40 Million2.71% of portfolio
-
Altra Vue Capital, LLC Bellevue, WA3.4MShares$37.3 Million2.78% of portfolio
About Avid Bioservices, Inc.
- Ticker CDMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,167,500
- Market Cap $683M
- Description
- Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...